Literature DB >> 6488681

Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency.

P E Graves, P E Fenster, R T MacFarland, F I Marcus, D Perrier.   

Abstract

The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1/2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488681     DOI: 10.1038/clpt.1984.229

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

Review 1.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 2.  Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.

Authors:  A D Mooradian
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  Bioavailability of the bis- and monodigitoxosides of digitoxigenin.

Authors:  P E Fenster; R T MacFarland; P E Graves; D Perrier; F I Marcus
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Digitoxin and its metabolites in patients with liver cirrhosis.

Authors:  A Nokhodian; S R Santos; W Kirch
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.